Genic Co. Ltd (123330.KQ) stock: key figures, P/E, revenue and dividend

Consumer Staples · Personal Care Products · South Korea · ISIN KR7123330003

Price
15,640.00 KRW
Market cap
122.38 bn KRW
P/E (2025)
6.48
P/S (2025)
1.56
Dividend yield
0.00 %
Net margin
24.15 %
Return on equity (ROE)
46.01 %
Return on assets (ROA)
33.41 %

Genic Co. Ltd financials

Fiscal year20242025
Revenue49.91 bn KRW78.20 bn KRW
Gross profit11.61 bn KRW22.55 bn KRW
Operating income6.02 bn KRW14.98 bn KRW
EBIT6.09 bn KRW15.14 bn KRW
Net income7.56 bn KRW18.89 bn KRW
Diluted EPS – continuing operations966.52 KRW2,413.72 KRW

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Genic Co. Ltd

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.